Novo Nordisk A/S ADR buy TD Cowen
Start price
03.02.26
/
50%
€48.60
Target price
03.02.27
-
Performance (%)
-19.84%
Price
19.06.26
€38.96
Summary
This prediction is currently active. The prediction for Novo Nordisk A/S ADR disappoints with a performance of -19.84%. This prediction currently runs until 03.02.27. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | -0.685% | -0.685% |
| iShares Core DAX® | 1.750% | 2.660% |
| iShares Nasdaq 100 | 4.301% | 6.593% |
| iShares Nikkei 225® | 9.895% | 18.278% |
| iShares S&P 500 | 2.542% | 3.062% |
Comments by TD_Cowen for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE:NVO) had its "buy" rating reaffirmed by analysts at TD Cowen.
Ratings data for NVO provided by MarketBeat
Stopped prediction by TD_Cowen for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€47.20
19.08.25
19.08.25
€60.08
19.08.26
19.08.26
-17.46%
19.06.26
19.06.26
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€93.00
04.12.23
04.12.23
€106.28
04.12.24
04.12.24
11.83%
05.12.24
05.12.24